NRG-BR003
NCT02488967
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
Status:
Recruiting
III
Phase
Adjuvant
Line of Therapy
Early Cancer
Disease Stage
Biomarker(s)
TNBC
Investigational
Product
carboplatin
Treatment Arms
o AC-->WP
o AC-->WP + carboplatin